ICER
ICER
  • ICER Analytics™
  • Donate
  • Who We Are
    • History & Impact
    • People
    • Independent Funding
    • Frequently Asked Questions (FAQs)
  • Our Approach
    • Methods & Process
    • Policies
  • Engage with ICER
    • Patients
    • Clinicians
    • Manufacturers
    • Prospective Employees
    • Committees & Boards
  • News & Insights
    • Press Releases
    • Commentaries
    • Journal Articles
    • Weekly View
  • Explore Our Research
    • Assessments
    • Policy Papers
    • ICER Calendar
    • ICER ANALYTICS™
News & Insights / Commentaries / CTAF Meeting on Hep C Featured in NYT Blog

CTAF Meeting on Hep C Featured in NYT Blog

In a recent post in the New York Times “Economix” blog, titled “The Dollar Value of an Extra Year of Life,” Professor Uwe E. Reinhardt of Princeton uses the March 2014 California Technology Assessment Forum (CTAF) meeting on Hepatitis C to explore the numerous issues that arise when society is faced with how to pay for a new, high-priced, effective drug.  CTAF is a core program of ICER.

Back to Top
  • Contact
  • Careers
  • Find a Report
  • Donate
  • ICER ANALYTICS™ LOGIN

OUR NEWSLETTER.

A weekly digest of the top news
on ICER and US drug pricing. Sign Up


CONTACT US

Institute for Clinical and Economic Review
Two Liberty Square, Ninth Floor, Boston, MA 02109
Get Directions

+1 (617) 528-4013

Email: info@icer.org

Media Inquiries: mediainquiries@icer.org

ICER
© ICER, 2021
  • Terms and Conditions
  • Privacy Policy
Twitter Linkedin